New

Hepatitis Vaccine Market

2021

Hepatitis Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Indication (Hepatitis A, Hepatitis B, Hepatitis C); Vaccine Type (Recombinant Vaccine, Inactivated Vaccine); Distribution Channel (Hospitals, Retail Pharmacy, Online Pharmacy)

| Report Code: TIPRE00007726 | No. of Pages: 151 | Category: Biotechnology | Status: Upcoming

Market Insights

Hepatitis Vaccine Market 2028 By Indication, Vaccine Type, Distribution Channel | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Hepatitis is a communicable disease caused due to hepatitis virus types A, B, and C, which leads to associated liver diseases such as Hepatitis A, hepatitis B, hepatitis C, liver cirrhosis, hepatocellular carcinoma, and liver failure. It may lead to the death of the infected person. The infection is spread due to the transmission of hepatitis A, and hepatitis B. Hepatitis vaccine is available for the prevention of both hepatitis A and hepatitis B, that prevents its occurrence by raising the immunity of the person, thereby avoiding complications such as liver failure and cancer.

MARKET SCOPE

The "Hepatitis vaccine market to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of hepatitis vaccine market with detailed market segmentation by of product, labeling method, application. The hepatitis vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in hepatitis vaccine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  n the basis of indication, the market is segmented into Hepatitis A, Hepatitis B, Hepatitis C.
  •  n the basis of vaccine type, the market is segmented into Recombinant Vaccine, Inactivated Vaccine.
  •  n the basis of distribution channel, the market is segmented into Hospitals, Retail Pharmacy, Online Pharmacy.

MARKET DYNAMICS
Drivers:

  •  Rise in the awareness of hepatitis infection prevention among people.
  •  Coupled with numerous government across the globe rolling out hepatitis immunization schedules.

Restraints:

  •  Highly expensive medicine.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the hepatitis vaccine market based on various segments. It also provides market size and forecast estimates from year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hepatitis vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting hepatitis vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting hepatitis vaccine market in these regions.

IMPACT OF COVID-19 ON HEPATITIS VACCINE MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the hepatitis vaccine market in 2020.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the hepatitis vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from hepatitis vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for hepatitis vaccine market in the global market. Below mentioned is the list of few companies engaged in the hepatitis vaccine market.

The report also includes the profiles of key players in hepatitis vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Sanofi
  •  Merck and Co., Inc.
  •  GlaxoSmithKline plc
  •  CSL
  •  Astellas Pharma Inc
  •  Gilead Sciences, Inc
  •  Dynavax Technologies
  •  Bharat Biotech
  •  VBI Vaccines Inc
  •  Johnson and Johnson
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hepatitis Vaccine Market - By Indication
1.3.2 Hepatitis Vaccine Market - By Vaccine Type
1.3.3 Hepatitis Vaccine Market - By Distribution Channel
1.3.4 Hepatitis Vaccine Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEPATITIS VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEPATITIS VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HEPATITIS VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. HEPATITIS VACCINE - GLOBAL MARKET OVERVIEW
6.2. HEPATITIS VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. HEPATITIS VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. HEPATITIS A
7.3.1. Overview
7.3.2. Hepatitis A Market Forecast and Analysis
7.4. HEPATITIS B
7.4.1. Overview
7.4.2. Hepatitis B Market Forecast and Analysis
7.5. HEPATITIS C
7.5.1. Overview
7.5.2. Hepatitis C Market Forecast and Analysis
8. HEPATITIS VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - VACCINE TYPE
8.1. OVERVIEW
8.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
8.3. RECOMBINANT VACCINE
8.3.1. Overview
8.3.2. Recombinant Vaccine Market Forecast and Analysis
8.4. INACTIVATED VACCINE
8.4.1. Overview
8.4.2. Inactivated Vaccine Market Forecast and Analysis
9. HEPATITIS VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Retail Pharmacies Market Forecast and Analysis
9.4. HOSPITAL PHARMACIES
9.4.1. Overview
9.4.2. Hospital Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. HEPATITIS VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Hepatitis Vaccine Market Overview
10.1.2 North America Hepatitis Vaccine Market Forecasts and Analysis
10.1.3 North America Hepatitis Vaccine Market Forecasts and Analysis - By Indication
10.1.4 North America Hepatitis Vaccine Market Forecasts and Analysis - By Vaccine Type
10.1.5 North America Hepatitis Vaccine Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Hepatitis Vaccine Market Forecasts and Analysis - By Countries
10.1.6.1 United States Hepatitis Vaccine Market
10.1.6.1.1 United States Hepatitis Vaccine Market by Indication
10.1.6.1.2 United States Hepatitis Vaccine Market by Vaccine Type
10.1.6.1.3 United States Hepatitis Vaccine Market by Distribution Channel
10.1.6.2 Canada Hepatitis Vaccine Market
10.1.6.2.1 Canada Hepatitis Vaccine Market by Indication
10.1.6.2.2 Canada Hepatitis Vaccine Market by Vaccine Type
10.1.6.2.3 Canada Hepatitis Vaccine Market by Distribution Channel
10.1.6.3 Mexico Hepatitis Vaccine Market
10.1.6.3.1 Mexico Hepatitis Vaccine Market by Indication
10.1.6.3.2 Mexico Hepatitis Vaccine Market by Vaccine Type
10.1.6.3.3 Mexico Hepatitis Vaccine Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Hepatitis Vaccine Market Overview
10.2.2 Europe Hepatitis Vaccine Market Forecasts and Analysis
10.2.3 Europe Hepatitis Vaccine Market Forecasts and Analysis - By Indication
10.2.4 Europe Hepatitis Vaccine Market Forecasts and Analysis - By Vaccine Type
10.2.5 Europe Hepatitis Vaccine Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Hepatitis Vaccine Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Hepatitis Vaccine Market
10.2.6.1.1 Germany Hepatitis Vaccine Market by Indication
10.2.6.1.2 Germany Hepatitis Vaccine Market by Vaccine Type
10.2.6.1.3 Germany Hepatitis Vaccine Market by Distribution Channel
10.2.6.2 France Hepatitis Vaccine Market
10.2.6.2.1 France Hepatitis Vaccine Market by Indication
10.2.6.2.2 France Hepatitis Vaccine Market by Vaccine Type
10.2.6.2.3 France Hepatitis Vaccine Market by Distribution Channel
10.2.6.3 Italy Hepatitis Vaccine Market
10.2.6.3.1 Italy Hepatitis Vaccine Market by Indication
10.2.6.3.2 Italy Hepatitis Vaccine Market by Vaccine Type
10.2.6.3.3 Italy Hepatitis Vaccine Market by Distribution Channel
10.2.6.4 Spain Hepatitis Vaccine Market
10.2.6.4.1 Spain Hepatitis Vaccine Market by Indication
10.2.6.4.2 Spain Hepatitis Vaccine Market by Vaccine Type
10.2.6.4.3 Spain Hepatitis Vaccine Market by Distribution Channel
10.2.6.5 United Kingdom Hepatitis Vaccine Market
10.2.6.5.1 United Kingdom Hepatitis Vaccine Market by Indication
10.2.6.5.2 United Kingdom Hepatitis Vaccine Market by Vaccine Type
10.2.6.5.3 United Kingdom Hepatitis Vaccine Market by Distribution Channel
10.2.6.6 Rest of Europe Hepatitis Vaccine Market
10.2.6.6.1 Rest of Europe Hepatitis Vaccine Market by Indication
10.2.6.6.2 Rest of Europe Hepatitis Vaccine Market by Vaccine Type
10.2.6.6.3 Rest of Europe Hepatitis Vaccine Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Hepatitis Vaccine Market Overview
10.3.2 Asia-Pacific Hepatitis Vaccine Market Forecasts and Analysis
10.3.3 Asia-Pacific Hepatitis Vaccine Market Forecasts and Analysis - By Indication
10.3.4 Asia-Pacific Hepatitis Vaccine Market Forecasts and Analysis - By Vaccine Type
10.3.5 Asia-Pacific Hepatitis Vaccine Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Hepatitis Vaccine Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Hepatitis Vaccine Market
10.3.6.1.1 Australia Hepatitis Vaccine Market by Indication
10.3.6.1.2 Australia Hepatitis Vaccine Market by Vaccine Type
10.3.6.1.3 Australia Hepatitis Vaccine Market by Distribution Channel
10.3.6.2 China Hepatitis Vaccine Market
10.3.6.2.1 China Hepatitis Vaccine Market by Indication
10.3.6.2.2 China Hepatitis Vaccine Market by Vaccine Type
10.3.6.2.3 China Hepatitis Vaccine Market by Distribution Channel
10.3.6.3 India Hepatitis Vaccine Market
10.3.6.3.1 India Hepatitis Vaccine Market by Indication
10.3.6.3.2 India Hepatitis Vaccine Market by Vaccine Type
10.3.6.3.3 India Hepatitis Vaccine Market by Distribution Channel
10.3.6.4 Japan Hepatitis Vaccine Market
10.3.6.4.1 Japan Hepatitis Vaccine Market by Indication
10.3.6.4.2 Japan Hepatitis Vaccine Market by Vaccine Type
10.3.6.4.3 Japan Hepatitis Vaccine Market by Distribution Channel
10.3.6.5 South Korea Hepatitis Vaccine Market
10.3.6.5.1 South Korea Hepatitis Vaccine Market by Indication
10.3.6.5.2 South Korea Hepatitis Vaccine Market by Vaccine Type
10.3.6.5.3 South Korea Hepatitis Vaccine Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Hepatitis Vaccine Market
10.3.6.6.1 Rest of Asia-Pacific Hepatitis Vaccine Market by Indication
10.3.6.6.2 Rest of Asia-Pacific Hepatitis Vaccine Market by Vaccine Type
10.3.6.6.3 Rest of Asia-Pacific Hepatitis Vaccine Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Hepatitis Vaccine Market Overview
10.4.2 Middle East and Africa Hepatitis Vaccine Market Forecasts and Analysis
10.4.3 Middle East and Africa Hepatitis Vaccine Market Forecasts and Analysis - By Indication
10.4.4 Middle East and Africa Hepatitis Vaccine Market Forecasts and Analysis - By Vaccine Type
10.4.5 Middle East and Africa Hepatitis Vaccine Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Hepatitis Vaccine Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Hepatitis Vaccine Market
10.4.6.1.1 South Africa Hepatitis Vaccine Market by Indication
10.4.6.1.2 South Africa Hepatitis Vaccine Market by Vaccine Type
10.4.6.1.3 South Africa Hepatitis Vaccine Market by Distribution Channel
10.4.6.2 Saudi Arabia Hepatitis Vaccine Market
10.4.6.2.1 Saudi Arabia Hepatitis Vaccine Market by Indication
10.4.6.2.2 Saudi Arabia Hepatitis Vaccine Market by Vaccine Type
10.4.6.2.3 Saudi Arabia Hepatitis Vaccine Market by Distribution Channel
10.4.6.3 U.A.E Hepatitis Vaccine Market
10.4.6.3.1 U.A.E Hepatitis Vaccine Market by Indication
10.4.6.3.2 U.A.E Hepatitis Vaccine Market by Vaccine Type
10.4.6.3.3 U.A.E Hepatitis Vaccine Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Hepatitis Vaccine Market
10.4.6.4.1 Rest of Middle East and Africa Hepatitis Vaccine Market by Indication
10.4.6.4.2 Rest of Middle East and Africa Hepatitis Vaccine Market by Vaccine Type
10.4.6.4.3 Rest of Middle East and Africa Hepatitis Vaccine Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Hepatitis Vaccine Market Overview
10.5.2 South and Central America Hepatitis Vaccine Market Forecasts and Analysis
10.5.3 South and Central America Hepatitis Vaccine Market Forecasts and Analysis - By Indication
10.5.4 South and Central America Hepatitis Vaccine Market Forecasts and Analysis - By Vaccine Type
10.5.5 South and Central America Hepatitis Vaccine Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Hepatitis Vaccine Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Hepatitis Vaccine Market
10.5.6.1.1 Brazil Hepatitis Vaccine Market by Indication
10.5.6.1.2 Brazil Hepatitis Vaccine Market by Vaccine Type
10.5.6.1.3 Brazil Hepatitis Vaccine Market by Distribution Channel
10.5.6.2 Argentina Hepatitis Vaccine Market
10.5.6.2.1 Argentina Hepatitis Vaccine Market by Indication
10.5.6.2.2 Argentina Hepatitis Vaccine Market by Vaccine Type
10.5.6.2.3 Argentina Hepatitis Vaccine Market by Distribution Channel
10.5.6.3 Rest of South and Central America Hepatitis Vaccine Market
10.5.6.3.1 Rest of South and Central America Hepatitis Vaccine Market by Indication
10.5.6.3.2 Rest of South and Central America Hepatitis Vaccine Market by Vaccine Type
10.5.6.3.3 Rest of South and Central America Hepatitis Vaccine Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HEPATITIS VACCINE MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HEPATITIS VACCINE MARKET, KEY COMPANY PROFILES
13.1. SANOFI
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. MERCK AND CO., INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. GLAXOSMITHKLINE PLC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CSL
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ASTELLAS PHARMA INC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GILEAD SCIENCES, INC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. DYNAVAX TECHNOLOGIES
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BHARAT BIOTECH
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. VBI VACCINES INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. JOHNSON AND JOHNSON SERVICES, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS


The List of Companies

1. Sanofi
2. Merck and Co., Inc.
3. GlaxoSmithKline plc
4. CSL
5. Astellas Pharma Inc
6. Gilead Sciences, Inc
7. Dynavax Technologies
8. Bharat Biotech
9. VBI Vaccines Inc
10. Johnson and Johnson Services, Inc.
11. Novartis AG
12. Bavarian Nordic


TIPRE00007726
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.